BioAtla (NASDAQ:BCAB – Get Free Report) is expected to be announcing its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.31) per share for the quarter. Parties are encouraged to explore the company’s upcoming Q3 2025 earningoverview page for the latest details on the […]

LifeMD (NASDAQ:LFMD – Get Free Report) will likely be announcing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.06) per share and revenue of $62.07 million for the quarter. Investors may visit the the company’s upcoming Q3 2025 earningresults page for the latest […]

Funko (NASDAQ:FNKO – Get Free Report) is projected to issue its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.0750) per share and revenue of $264.9440 million for the quarter. Investors can check the company’s upcoming Q3 2025 earningsummary page for the latest details […]

Hanesbrands (NYSE:HBI – Get Free Report) is expected to be posting its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect Hanesbrands to post earnings of $0.16 per share and revenue of $905.3650 million for the quarter. Hanesbrands has set its Q3 2025 guidance at 0.160-0.160 EPS. FY 2025 guidance at […]

York Water (NASDAQ:YORW – Get Free Report) is anticipated to post its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect York Water to post earnings of $0.38 per share and revenue of $21.00 million for the quarter. Individuals may review the information on the company’s upcoming Q3 2025 earningreport for […]

VYNE Therapeutics (NASDAQ:VYNE – Get Free Report) will likely be posting its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect VYNE Therapeutics to post earnings of ($0.19) per share for the quarter. Individuals may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call […]

Americold Realty Trust (NYSE:COLD – Get Free Report) is projected to issue its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of $0.35 per share and revenue of $659.5090 million for the quarter. Parties can check the company’s upcoming Q3 2025 earningsummary page for the […]

Esperion Therapeutics (NASDAQ:ESPR – Get Free Report) is expected to be announcing its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of $0.06 per share and revenue of $78.3340 million for the quarter. Investors are encouraged to explore the company’s upcoming Q3 2025 earningoverview page […]

Cibus (NASDAQ:CBUS – Get Free Report) is projected to issue its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of ($0.56) per share and revenue of $1.3910 million for the quarter. Parties may review the information on the company’s upcoming Q3 2025 earningreport for the […]

Upstream Bio (NASDAQ:UPB – Get Free Report) is projected to post its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect Upstream Bio to post earnings of ($0.77) per share and revenue of $0.6460 million for the quarter. Individuals can check the company’s upcoming Q3 2025 earningsummary page for the latest […]

DiamondRock Hospitality (NYSE:DRH – Get Free Report) is expected to be announcing its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of $0.26 per share and revenue of $277.4510 million for the quarter. DiamondRock Hospitality has set its FY 2025 guidance at 0.960-1.060 EPS.Investors are […]

Air Products and Chemicals (NYSE:APD – Get Free Report) is expected to release its Q4 2025 results before the market opens on Thursday, November 6th. Analysts expect Air Products and Chemicals to post earnings of $3.42 per share and revenue of $3.1822 billion for the quarter. Investors can check the company’s upcoming Q4 2025 earningsummary […]

Tyra Biosciences (NASDAQ:TYRA – Get Free Report) is projected to release its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect Tyra Biosciences to post earnings of ($0.50) per share for the quarter. Interested persons can check the company’s upcoming Q3 2025 earningsummary page for the latest details on the call […]

Cars.com (NYSE:CARS – Get Free Report) will likely be releasing its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect Cars.com to post earnings of $0.50 per share and revenue of $181.3670 million for the quarter. Interested persons may visit the the company’s upcoming Q3 2025 earningresults page for the latest […]

Middlesex Water (NASDAQ:MSEX – Get Free Report) is expected to release its Q3 2025 results after the market closes on Friday, October 31st. Analysts expect Middlesex Water to post earnings of $0.86 per share and revenue of $56.0830 million for the quarter. Parties can find conference call details on the company’s upcoming Q3 2025 earningreport […]

Church & Dwight (NYSE:CHD – Get Free Report) will likely be releasing its Q3 2025 results before the market opens on Friday, October 31st. Analysts expect Church & Dwight to post earnings of $0.75 per share and revenue of $1.5371 billion for the quarter. Church & Dwight has set its FY 2025 guidance at 3.440-3.510 […]

Ligand Pharmaceuticals (NASDAQ:LGND – Get Free Report) is anticipated to announce its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect the company to announce earnings of $1.96 per share and revenue of $58.7070 million for the quarter. Ligand Pharmaceuticals has set its FY 2025 guidance at 6.700-7.000 EPS.Investors are encouraged […]

Granite Ridge Resources (NYSE:GRNT – Get Free Report) is anticipated to issue its Q3 2025 results after the market closes on Thursday, November 6th. Analysts expect the company to announce earnings of $0.13 per share and revenue of $123.00 million for the quarter. Parties may review the information on the company’s upcoming Q3 2025 earningreport […]

Corbus Pharmaceuticals (NASDAQ:CRBP – Get Free Report) will likely be posting its Q3 2025 results before the market opens on Thursday, November 6th. Analysts expect Corbus Pharmaceuticals to post earnings of ($1.80) per share for the quarter. Individuals may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call […]